Transjugular intrahepatic portosystemic shunt for ascites

Which patients will benefit?

Francesco Salerno, Massimo Cazzaniga

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) is a radiological interventional procedure useful in portal hypertension- related complications. It is able to resolve variceal bleeding and refractory ascites. However, it can lead to serious side effects such as refractory encephalopathy, cardiac failure, and end- stage liver failure. Patients with refractory ascites represent the most frequent indication for TIPS. Clinicians are challenged by the necessity to select the best candidates for TIPS, so that the procedure can be successful as far as both efficacy and survival are concerned. The correct process to select TIPS for cirrhotic patients with ascites includes different steps: first, patients with absolute contraindications, such cardiopulmonary dysfunction or too severe liver failure, should be excluded, and second, criteria to predict post- TIPS survival should be considered. The most effective predictors of survival are serum creatinine, serum bilirubin, serum sodium, age and MELD or Child- Pugh scores. According to an arbitrary choice of two thresholds of different risks for each variable, we propose a simple estimation of the whole risk after TIPS placement.

Original languageEnglish
Title of host publicationAscites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment
PublisherS. Karger AG
Pages52-64
Number of pages13
Volume28
ISBN (Print)9783805595926, 9783805595919
DOIs
Publication statusPublished - Dec 21 2010

Fingerprint

Transjugular Intrahepatic Portasystemic Shunt
Ascites
Liver Failure
Survival
Serum
Brain Diseases
Portal Hypertension
Bilirubin
Creatinine
Heart Failure
Sodium
Hemorrhage

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Salerno, F., & Cazzaniga, M. (2010). Transjugular intrahepatic portosystemic shunt for ascites: Which patients will benefit? In Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment (Vol. 28, pp. 52-64). S. Karger AG. https://doi.org/10.1159/000318924

Transjugular intrahepatic portosystemic shunt for ascites : Which patients will benefit? / Salerno, Francesco; Cazzaniga, Massimo.

Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment. Vol. 28 S. Karger AG, 2010. p. 52-64.

Research output: Chapter in Book/Report/Conference proceedingChapter

Salerno, F & Cazzaniga, M 2010, Transjugular intrahepatic portosystemic shunt for ascites: Which patients will benefit? in Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment. vol. 28, S. Karger AG, pp. 52-64. https://doi.org/10.1159/000318924
Salerno F, Cazzaniga M. Transjugular intrahepatic portosystemic shunt for ascites: Which patients will benefit? In Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment. Vol. 28. S. Karger AG. 2010. p. 52-64 https://doi.org/10.1159/000318924
Salerno, Francesco ; Cazzaniga, Massimo. / Transjugular intrahepatic portosystemic shunt for ascites : Which patients will benefit?. Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment. Vol. 28 S. Karger AG, 2010. pp. 52-64
@inbook{f62cad4858fa45bd99fcc97e2d0d27db,
title = "Transjugular intrahepatic portosystemic shunt for ascites: Which patients will benefit?",
abstract = "Transjugular intrahepatic portosystemic shunt (TIPS) is a radiological interventional procedure useful in portal hypertension- related complications. It is able to resolve variceal bleeding and refractory ascites. However, it can lead to serious side effects such as refractory encephalopathy, cardiac failure, and end- stage liver failure. Patients with refractory ascites represent the most frequent indication for TIPS. Clinicians are challenged by the necessity to select the best candidates for TIPS, so that the procedure can be successful as far as both efficacy and survival are concerned. The correct process to select TIPS for cirrhotic patients with ascites includes different steps: first, patients with absolute contraindications, such cardiopulmonary dysfunction or too severe liver failure, should be excluded, and second, criteria to predict post- TIPS survival should be considered. The most effective predictors of survival are serum creatinine, serum bilirubin, serum sodium, age and MELD or Child- Pugh scores. According to an arbitrary choice of two thresholds of different risks for each variable, we propose a simple estimation of the whole risk after TIPS placement.",
author = "Francesco Salerno and Massimo Cazzaniga",
year = "2010",
month = "12",
day = "21",
doi = "10.1159/000318924",
language = "English",
isbn = "9783805595926",
volume = "28",
pages = "52--64",
booktitle = "Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment",
publisher = "S. Karger AG",

}

TY - CHAP

T1 - Transjugular intrahepatic portosystemic shunt for ascites

T2 - Which patients will benefit?

AU - Salerno, Francesco

AU - Cazzaniga, Massimo

PY - 2010/12/21

Y1 - 2010/12/21

N2 - Transjugular intrahepatic portosystemic shunt (TIPS) is a radiological interventional procedure useful in portal hypertension- related complications. It is able to resolve variceal bleeding and refractory ascites. However, it can lead to serious side effects such as refractory encephalopathy, cardiac failure, and end- stage liver failure. Patients with refractory ascites represent the most frequent indication for TIPS. Clinicians are challenged by the necessity to select the best candidates for TIPS, so that the procedure can be successful as far as both efficacy and survival are concerned. The correct process to select TIPS for cirrhotic patients with ascites includes different steps: first, patients with absolute contraindications, such cardiopulmonary dysfunction or too severe liver failure, should be excluded, and second, criteria to predict post- TIPS survival should be considered. The most effective predictors of survival are serum creatinine, serum bilirubin, serum sodium, age and MELD or Child- Pugh scores. According to an arbitrary choice of two thresholds of different risks for each variable, we propose a simple estimation of the whole risk after TIPS placement.

AB - Transjugular intrahepatic portosystemic shunt (TIPS) is a radiological interventional procedure useful in portal hypertension- related complications. It is able to resolve variceal bleeding and refractory ascites. However, it can lead to serious side effects such as refractory encephalopathy, cardiac failure, and end- stage liver failure. Patients with refractory ascites represent the most frequent indication for TIPS. Clinicians are challenged by the necessity to select the best candidates for TIPS, so that the procedure can be successful as far as both efficacy and survival are concerned. The correct process to select TIPS for cirrhotic patients with ascites includes different steps: first, patients with absolute contraindications, such cardiopulmonary dysfunction or too severe liver failure, should be excluded, and second, criteria to predict post- TIPS survival should be considered. The most effective predictors of survival are serum creatinine, serum bilirubin, serum sodium, age and MELD or Child- Pugh scores. According to an arbitrary choice of two thresholds of different risks for each variable, we propose a simple estimation of the whole risk after TIPS placement.

UR - http://www.scopus.com/inward/record.url?scp=84925862250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925862250&partnerID=8YFLogxK

U2 - 10.1159/000318924

DO - 10.1159/000318924

M3 - Chapter

SN - 9783805595926

SN - 9783805595919

VL - 28

SP - 52

EP - 64

BT - Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment

PB - S. Karger AG

ER -